{"version":1,"type":"story","url":"https://digestai.news/story/researchers-introduce-specopt-for-agentic-molecule-specificity-optimiz","json":"https://digestai.news/story/researchers-introduce-specopt-for-agentic-molecule-specificity-optimiz.json","markdown":"https://digestai.news/story/researchers-introduce-specopt-for-agentic-molecule-specificity-optimiz.md","slug":"researchers-introduce-specopt-for-agentic-molecule-specificity-optimiz","headline":"Researchers introduce SpecOpt for agentic molecule specificity optimization","summary":"Off‑target protein binding causes many adverse effects in small‑molecule drugs, yet most design methods create new selective compounds instead of improving existing ones. The authors propose a new task, specificity optimization (SpecOpt), which seeks constrained structural changes to a known drug that boost its binding preference for the intended target while keeping its drug‑like properties.\n\nTo evaluate SpecOpt they built a benchmark from ChEMBL data, selecting 915 compounds with curated target annotations and measured off‑target activities. An agentic pipeline docks each compound to its target and off‑targets, extracts residue‑aware atom‑protein contacts, and feeds the differential interactions to a large language model that suggests modifications. The resulting candidates must satisfy similarity, ADMET, and docking selectivity filters. The agent improves the target‑off‑target binding gap for 84.8% of the compounds, shifting the mean gap from –0.72 to +0.47 kcal/mol while retaining a mean Tanimoto similarity of 0.72.\n\nAblation experiments show that providing residue‑specific contact information is crucial: replacing residues with binary contact indicators removes any improvement on all 29 ablation compounds. These findings define SpecOpt as a distinct molecular design problem and demonstrate that residue‑aware differential interactions can effectively enhance drug specificity.","keyPoints":["SpecOpt task aims to modify existing drugs to increase binding preference for intended target over off‑targets while preserving similarity.","On a 915‑compound benchmark, the agent improved the binding gap for 84.8% of molecules, raising mean gap from –0.72 to +0.47 kcal/mol.","Ablation showed residue‑specific contact information is essential; removing it eliminated improvements on all 29 test compounds."],"whyItMatters":"Improving off‑target selectivity of existing drugs can reduce adverse effects without redesigning molecules, offering a practical path for safer therapeutics.","category":{"slug":"research","name":"Research","url":"https://digestai.news/category/research"},"entities":{"companies":[],"models":[],"people":[]},"firstPublishedAt":"2026-09-21T04:00:00Z","updatedAt":"2026-09-21T04:00:00Z","sourceCount":1,"hasPrimarySource":true,"sources":[{"outlet":"arXiv cs.AI","title":"SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity","url":"https://arxiv.org/abs/2609.21165","publishedAt":"2026-09-21T04:00:00Z","type":"primary","primary":true,"lead":true}],"sourceNotes":null,"discussions":[],"thread":null,"cite":{"text":"Digest AI, \"Researchers introduce SpecOpt for agentic molecule specificity optimization\", 21 September 2026, https://digestai.news/story/researchers-introduce-specopt-for-agentic-molecule-specificity-optimiz","publisher":"Digest AI","title":"Researchers introduce SpecOpt for agentic molecule specificity optimization","datePublished":"2026-09-21T04:00:00Z","url":"https://digestai.news/story/researchers-introduce-specopt-for-agentic-molecule-specificity-optimiz"},"generatedBy":"Written by Digest AI's editorial model from the linked sources; the sources are the record.","license":"Headlines, digests and key points are written by Digest AI and may be quoted with a link to the story page. Linked articles belong to their publishers. Terms: https://digestai.news/terms#reuse"}